01 Apr 2021 Press Release Dimitrios Makrakis is leaving the NETZSCH Group after more than 34 years. Now his successor has been determined. The NETZSCH Business Unit Grinding and Dispersing has a new Managing Director. 55-year-old Ingo Rädisch will take over the reins of the Business Unit on April 1, 2021, and will face new challenges.... Read more
CE marked assay based on well-established ELISA technology expands EUROIMMUN’s offerings for labs that seek to understand immune response to COVID-19 WALTHAM, Mass. – April 1, 2021 – EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the SARS-CoV-2 NeutraLISATM assay, a surrogate neutralization test intended for the detection of neutralizing antibodies against SARS-CoV-2,... Read more
Thermo Fisher Scientific Announces New System for Flexible, Automated Sample Purification KingFisher Apex Purification System isolates nucleic acids, proteins and cells with customizable protocols CARLSBAD, Calif., April 1, 2021 /PRNewswire/ — Thermo Fisher Scientific today launched the Thermo Scientific KingFisher Apex Purification System, a high-throughput sample purification instrument designed for scientists who need to automate the... Read more
The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood sample, which means less confirmatory testing and, potentially, faster diagnosis for patients Clear and quick diagnosis of acute infection allows physicians to decide faster on treatment for transplant patients The EBV panel can be used to rule out other acute infections,... Read more
Tue 30th March 2021 Oxford Nanopore has announced that Tim Cowper is taking the role of Chief Financial Officer, and Jordan Herman has joined as General Counsel. “We’re delighted to announce that Tim will be taking on the important role of CFO, and to welcome Jordan to the Company after working with him for so... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN), today announced that it disagrees with, and will oppose, the U.S. Federal Trade Commission (FTC)’s challenge to its previously announced acquisition of GRAIL, a pre-commercial company founded to accelerate early screening of cancer. Illumina will pursue its right to proceed with the transaction, the impact of which would accelerate... Read more
Chicago – 30 March 2021 – Driven by pandemic realities and clinical demand for portable and intelligent point-of-care ultrasound (POCUS), GE Healthcare today unveiled Venue Fit™, a streamlined and compact POCUS system, alongside an industry-first AI offering for cardiac imaging on the Venue™ and Venue Go™. The Venue Fit is the smallest system in GE... Read more
Evrysdi has proven efficacy in adults, children and babies two months and older, as shown in two pivotal clinical trials Roche is actively engaging with health authorities in the EU to achieve broad and rapid access for people with SMA More than 3,000 patients now treated with Evrysdi in clinical trial, compassionate use and real-world... Read more
CRISPRi Innovations Provide Expanded Experimental Options and Flexibility For Researchers Facilitating Disease & Drug Research WALTHAM, Mass.–(BUSINESS WIRE)–Mar. 29, 2021– Horizon Discovery, a PerkinElmer, Inc. (NYSE:PKI) company, today announced that its gene editing and modulation portfolio is expanding to include a new family of CRISPR modulation (CRISPRmod) reagents for CRISPR interference (CRISPRi). CRISPRi enables scientists... Read more
BILLERICA, Mass.–(BUSINESS WIRE)– At the Experimental Nuclear Magnetic Resonance Conference 2021 (ENC), Bruker Corporation (Nasdaq: BRKR) announces that the Forschungszentrum Juelich (FZJ), Germany has expanded its research into functional structural biology in neurodegenerative diseases with the addition of a 1.2 GHz Avance™ nuclear magnetic resonance (NMR) spectrometer. Novel GHz-class NMR technology at FZ Juelich now... Read more